HF
INO icon

HRT Financial’s Inovio Pharmaceuticals INO Stock Holding History

HRT Financial’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82K Buy
+75,000
New +$89K ﹤0.01% 3665
2021
Q2 		– Sell
-5,242
Closed -$583K – 3158
2021
Q1 		$583K Buy
+5,242
New +$689K 0.01% 1650

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HRT Financial's INO Position: Q2 2026 in Review

HRT Financial increased its Inovio Pharmaceuticals (INO) stake by 987% in Q2 2026, buying an estimated $151K and bringing the position to 140,432 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #3482.

HRT Financial first reported a position in INO in Q2 2015 and has held it in 13 quarters since. The position peaked at $1.06M in Q1 2024. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • HRT Financial held 140,432 shares of Inovio Pharmaceuticals worth $154K as of Q2 2026.
  • HRT Financial bought 127,515 Inovio Pharmaceuticals shares in Q2 2026, an estimated $151K.
  • Inovio Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3482 holding.
  • HRT Financial first reported a position in Inovio Pharmaceuticals in Q2 2015 and has held it in 13 quarters since.
  • HRT Financial's Inovio Pharmaceuticals position peaked at $1.06M in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.